Drug Profile
ZD 0490
Alternative Names: D 0490; ICI 0490; ICI D 0490Latest Information Update: 09 Aug 2000
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Antineoplastics; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Colorectal cancer
Most Recent Events
- 09 Aug 2000 Discontinued-I for Colorectal cancer in United Kingdom (Unknown route)
- 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed
- 14 Jul 1998 Profile reviewed but no significant updates made